Yu Abe

Clinical and immunological evaluation of zoledronate-activated Vγ9γδ T-cell-based immunotherapy for patients with multiple myeloma

Yu Abe, Masato Muto, Mie Nieda et al. · Experimental Hematology · 2009 · 168 citations

Cooperation of specific ICAM-3 grabbing nonintegrin-related 1 (SIGNR1) and complement receptor type 3 (CR3) in the uptake of oligomannose-coated liposomes by macrophages

Hideaki Takagi, Maki Numazaki, T. Kajiwara et al. · Glycobiology · 2008 · 37 citations · Full text

Immunology, Immune Regulation, Immunologic Mechanism +20

Phase 1 study in Japan of siltuximab, an anti-IL-6 monoclonal antibody, in relapsed/refractory multiple myeloma

Kenshi Suzuki, Michinori Ogura, Yu Abe et al. · International Journal of Hematology · 2015 · 30 citations

Hematological Malignancy, Anti-il-6 Monoclonal Antibody, Autoimmune Disease +11

Amelioration of NK cell function driven by Vα24 + invariant NKT cell activation in multiple myeloma

Tomonori Iyoda, Satoru Yamasaki, Michihiro Hidaka et al. · Clinical Immunology · 2017 · 22 citations

Hematological Malignancy, Nk Cell Function, Cancer Immunosurveillance +8

Contribution of Complement Component C3 and Complement Receptor Type 3 to Carbohydrate-dependent Uptake of Oligomannose-coated Liposomes by Peritoneal Macrophages

Yu Abe, Yasuhiro Kuroda, Noritaka Kuboki et al. · The Journal of Biochemistry · 2008 · 19 citations

Complement Component C3, Proteinlipid Interaction, Immunology +20